AIMT
Aimmune Therapeutics

4,043
Loading...
Loading...
Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The firm product include Palforzia, which is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis that may occur with accidental exposure to peanut. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Aimmune Therapeutics Inc?
What is the 52-week high for Aimmune Therapeutics Inc?
What is the 52-week low for Aimmune Therapeutics Inc?
What is Aimmune Therapeutics Inc stock price today?
What was Aimmune Therapeutics Inc stock price yesterday?
What is the PE ratio of Aimmune Therapeutics Inc?
What is the Price-to-Book ratio of Aimmune Therapeutics Inc?
What is the 50-day moving average of Aimmune Therapeutics Inc?

Latest AIMT News

View
No AIMT news at the moment.

Advertisement. Remove ads.

Advertisement. Remove ads.